India  

DCGI approves DRDO's anti-COVID drug helpful in faster recovery

Video Credit: ANI - Duration: 02:44s - Published
DCGI approves DRDO's anti-COVID drug helpful in faster recovery

DCGI approves DRDO's anti-COVID drug helpful in faster recovery

Drugs Controller General of India (DCGI) on May 08 approved emergency use DRDO's anti-COVID drug which the agency said will be helpful in faster recovery of hospitalised patients.

While speaking to ANI, Institute of Nuclear Medicine and Allied Sciences (INMAS-DRDO) scientists spoken about drug 2-deoxy-D-glucose (2-DG).

The drug will be of immense benefit to the people suffering from COVID-19.


You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Bust Premiership trio owe £30m in unpaid Covid loans

London Irish, Wasps and Worcester went out of business needing to repay more than £30m of Covid relief loans, a National Audit Office report says.
BBC Sport

Defence Research and Development Organisation Defence Research and Development Organisation Government agency in India

India's Successful Test of Hypersonic Missile Marks a New Era in Defense Technology| WATCH [Video]

India's Successful Test of Hypersonic Missile Marks a New Era in Defense Technology| WATCH

India has successfully test-fired its long-range hypersonic missile, joining a select group of countries including Russia and China. The missile, launched by the Defence Research and Development Organisation (DRDO) on November 16, 2024, can reach speeds over Mach 5 (more than 6,174 km/h) and target both sea and land-based objectives. This achievement underscores India's growing stature as a global military power. #IndiaHypersonic #DRDO #IndianDefense #MilitaryTechnology #HypersonicMissile #Mach5 #StrategicAdvantage #SelfReliance #GlobalDefense #IndiaRising #Oneindia #OneindiaNews ~HT.178~PR.362~ED.155~GR.124~

Credit: Oneindia    Duration: 06:01Published

Related news from verified sources

Potential cancer drug repurposed for Covid-19 by DRDO, Dr Reddy's gets DCGI nod for emergency use

A potential cancer drug repurposed for Covid-19 treatment -- 2-deoxy-D-glucose (2-DG) – has...
IndiaTimes - Published


Related videos from verified sources

Covid-19: Rajnath Singh released first batch of anti-covid drug 2-DG | Oneindia News [Video]

Covid-19: Rajnath Singh released first batch of anti-covid drug 2-DG | Oneindia News

The first batch of anti-Covid oral drug 2-DG, developed by the DRDO, was released on Monday by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan. Even as the country is reeling under..

Credit: Oneindia     Duration: 02:34Published
42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials [Video]

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials

Institute of Nuclear Medicine and Allied Sciences-DRDO scientist Dr Sudhir Chandna on drug 2-deoxy-D-glucose (2-DG) while speaking to ANI informed about the observations of the medicine's clinical..

Credit: ANI     Duration: 01:59Published
Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen [Video]

Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen

From DCGI approving new anti-Covid drug, to health ministry issues new rules for hospital admissions, here are the top updates on the coronavirus. DCGI approved a new anti-Covid oral drug, which has..

Credit: HT Digital Content     Duration: 03:24Published